NVIDIA's next-gen AI PC processor was expected at CES 2025 but wasn't revealed: new leaks tease RTX 5070 levels of ...
Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.
Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...
AMD promised eventual “mobile gaming dominance” back in 2022, and it feels like we’re getting closer every day. Today, the ...
AMD's Ryzen AI Max chips came as a huge surprise at CES 2025. They're basically super-powered versions of the company's Ryzen ...
The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...
PowerColor's new Radeon RX 9070 XT Reaper is based on AMD;s reference design and it's a sleek and minimal two-slot GPU ready ...
Chip designer AMD said Wednesday that it will invest $20 million in Absci, the Vancouver company that aims to use artificial ...
AMD served up a smorgasbord of new laptop processor lines: gamer-riffic X3D chips, a workstation-minded Ryzen AI Max family, ...
Read here for an update on AMD's product roadmap, AI hardware challenges, valuation, and market sentiment for potential ...